Table 4. FCN2 haplotypes in Cutaneous Leishmaniasis patients and healthy controls.
| FCN2 haploytpes (−986/−602/−4/+6359/+6424) | Patients n = 452 (%) | Healthy controls n = 572 (%) | OR (95% CI) | P |
| AAACG | 79 (17.5) | 118 (20.6) | NS | |
| GGACG | 160 (35.4) | 206 (36.0) | NS | |
| AGGTG | 116 (25.7) | 136 (23.8) | NS | |
| AGACG | 42 (9.3) | 28 (4.9) | 2.0 (1.2–3.4) | 0.006 |
| GGACT | 37 (8.2) | 46 (8.0) | NS | |
| AGGCG | 9 (2.0) | 3 (0.5) | NS | |
| GGATG | 6 (1.3) | 15 (2.6) | NS | |
| GGATT | 1 (0.2) | 6 (1.0) | NS | |
| AGATG | 0 | 3 (0.5) | NS | |
| AAATG | 1 (0.2) | 4 (0.7) | NS | |
| GGGTG | 0 | 3 (0.5) | NS | |
| AGGTT | 0 | 2 (0.3) | NS | |
| GAACG | 0 | 2 (0.3) | NS | |
| AAACT | 1 (0.2) | 0 | NS | |